BACKGROUND: Current molecular diagnostic methods have detected rhinovirus RNA in a high proportion of asymptomatic infants and children, raising the question of the clinical significance of these findings. This study investigates the prevalence of prolonged rhinovirus RNA presence in the upper respiratory tract of infants during the first year of life. METHODS: In a longitudinal study, infants were followed from birth up to 12 months. Nasopharyngeal specimens were collected monthly (months 1-6 and month 9) and during an upper respiratory infection. Rhinoviruses were detected by quantitative reverse-transcription polymerase chain reaction. Presence of repeated rhinovirus RNA was evaluated by nucleotide sequence analysis. RESULTS: A total of 2153 specimens from 362 infants were studied; 341 distinct rhinovirus infections in 216 infants were identified. Follow-up specimens were available within 30 days for 179 infections, creating the sample set to assess prolonged rhinovirus presence. Of the 179 infections, 46 involved the detection of the same rhinovirus strain in repeated specimens, including 8 events of prolonged presence of the same strain (detected in specimens collected >30 days apart), representing 4.5% of the evaluable rhinovirus infections. There were 26 events in which a rhinovirus strain was replaced by a different strain within a 30-day interval, representing 14.5% of the 179 infections. CONCLUSIONS: Although rhinovirus infections are common in healthy infants, prolonged presence of rhinovirus RNA in the respiratory tract after an upper respiratory infection was uncommon (<5%). Detection of rhinovirus RNA in an infant most likely represents an infection within a 30-day period.
BACKGROUND: Current molecular diagnostic methods have detected rhinovirus RNA in a high proportion of asymptomatic infants and children, raising the question of the clinical significance of these findings. This study investigates the prevalence of prolonged rhinovirus RNA presence in the upper respiratory tract of infants during the first year of life. METHODS: In a longitudinal study, infants were followed from birth up to 12 months. Nasopharyngeal specimens were collected monthly (months 1-6 and month 9) and during an upper respiratory infection. Rhinoviruses were detected by quantitative reverse-transcription polymerase chain reaction. Presence of repeated rhinovirus RNA was evaluated by nucleotide sequence analysis. RESULTS: A total of 2153 specimens from 362 infants were studied; 341 distinct rhinovirus infections in 216 infants were identified. Follow-up specimens were available within 30 days for 179 infections, creating the sample set to assess prolonged rhinovirus presence. Of the 179 infections, 46 involved the detection of the same rhinovirus strain in repeated specimens, including 8 events of prolonged presence of the same strain (detected in specimens collected >30 days apart), representing 4.5% of the evaluable rhinovirus infections. There were 26 events in which a rhinovirus strain was replaced by a different strain within a 30-day interval, representing 14.5% of the 179 infections. CONCLUSIONS: Although rhinovirus infections are common in healthy infants, prolonged presence of rhinovirus RNA in the respiratory tract after an upper respiratory infection was uncommon (<5%). Detection of rhinovirus RNA in an infant most likely represents an infection within a 30-day period.
Authors: Nigel Bourne; Richard B Pyles; MinKyung Yi; Ronald L Veselenak; Melissa M Davis; Stanley M Lemon Journal: Antiviral Res Date: 2005-08 Impact factor: 5.970
Authors: Ville Peltola; Matti Waris; Riikka Osterback; Petri Susi; Olli Ruuskanen; Timo Hyypiä Journal: J Infect Dis Date: 2008-02-01 Impact factor: 5.226
Authors: Wai-Ming Lee; Christin Kiesner; Tressa Pappas; Iris Lee; Kris Grindle; Tuomas Jartti; Bogdan Jakiela; Robert F Lemanske; Peter A Shult; James E Gern Journal: PLoS One Date: 2007-10-03 Impact factor: 3.240
Authors: Leigh M Howard; Monika Johnson; John V Williams; Yuwei Zhu; Ana I Gil; Kathryn M Edwards; Marie R Griffin; Claudio F Lanata; Carlos G Grijalva Journal: Pediatr Infect Dis J Date: 2015-10 Impact factor: 2.129
Authors: Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews Journal: Clin Microbiol Rev Date: 2018-12-12 Impact factor: 26.132
Authors: Stephen J Barenkamp; Tasnee Chonmaitree; Anders P Hakansson; Terho Heikkinen; Samantha King; Johanna Nokso-Koivisto; Laura A Novotny; Janak A Patel; Melinda Pettigrew; W Edward Swords Journal: Otolaryngol Head Neck Surg Date: 2017-04 Impact factor: 3.497
Authors: Santtu Heinonen; Tuomas Jartti; Carla Garcia; Silvia Oliva; Cynthia Smitherman; Esperanza Anguiano; Wouter A A de Steenhuijsen Piters; Tytti Vuorinen; Olli Ruuskanen; Blerta Dimo; Nicolas M Suarez; Virginia Pascual; Octavio Ramilo; Asuncion Mejias Journal: Am J Respir Crit Care Med Date: 2016-04-01 Impact factor: 21.405
Authors: David P McCormick; Kristofer Jennings; Linda C Ede; Pedro Alvarez-Fernandez; Janak Patel; Tasnee Chonmaitree Journal: Int J Pediatr Otorhinolaryngol Date: 2015-12-18 Impact factor: 1.675
Authors: Anne J Blaschke; E Kent Korgenski; Jacob Wilkes; Angela P Presson; Emily A Thorell; Andrew T Pavia; Elizabeth D Knackstedt; Carolyn Reynolds; Jeff E Schunk; Judy A Daly; Carrie L Byington Journal: Pediatrics Date: 2018-01-17 Impact factor: 7.124